Leioa-Vizcaya, Spain

Alfredo Rodríguez-Antigüedad Zarranz


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alfredo Rodríguez-Antigüedad Zarranz

Introduction

Alfredo Rodríguez-Antigüedad Zarranz is a notable inventor based in Leioa-Vizcaya, Spain. He has made significant contributions to the field of medical diagnostics, particularly in relation to demyelinating diseases. His work focuses on innovative methods that enhance the understanding and treatment of these complex conditions.

Latest Patents

Rodríguez-Antigüedad Zarranz holds a patent for a "Method for the diagnosis and prognosis of demyelinating diseases." This invention utilizes glutamate transporters, glutamate, and EGF to detect the presence of demyelinating diseases in a subject. It also helps determine the status or severity of the disease and monitor the effects of therapies administered to affected individuals. The patent emphasizes the use of these markers for the identification, development, and evaluation of compounds aimed at treating such diseases, with a particular focus on multiple sclerosis (MS). He has 1 patent to his name.

Career Highlights

Rodríguez-Antigüedad Zarranz is affiliated with the Universidad del País Vasco, where he contributes to research and innovation in the medical field. His work is characterized by a commitment to advancing the understanding of demyelinating diseases and improving therapeutic approaches.

Collaborations

He has collaborated with esteemed colleagues, including Carlos Matute Almau and María Domercq García, to further enhance the impact of his research and innovations.

Conclusion

Alfredo Rodríguez-Antigüedad Zarranz exemplifies the spirit of innovation in medical research, particularly in the diagnosis and treatment of demyelinating diseases. His contributions are paving the way for new therapeutic strategies and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…